ViroVet's Series A - II Round

ViroVet raised a round of funding on October 06, 2017. Investors include Capricorn Venture Partners.

ViroVet is a biopharmaceutical company active in the development of vaccines and antiviral drugs for livestock. These vaccines are tailor-made to maximize efficacy and minimize safety concerns.This te…

Articles about ViroVet's Series A - II Round: